MAT
41
2
APH
53
3
HBI
53
4
ICE
53
5
OI
23
3
ABBV
40
5
SO
48
6
WFC
58
8
BAX
38
2
LMT
29
-5
ITW
45
2
KHC
11
2
AAPL
64
3
SBUX
29
-2
GE
60
5
HSIC
42
2
EMC
30
-26
KSS
36
2
MMC
46
5
MMM
35
3
MAT
41
2
APH
53
3
HBI
53
4
ICE
53
5
OI
23
3
ABBV
40
5
SO
48
6
WFC
58
8
BAX
38
2
LMT
29
-5
ITW
45
2
KHC
11
2
AAPL
64
3
SBUX
29
-2
GE
60
5
HSIC
42
2
EMC
30
-26
KSS
36
2
MMC
46
5
MMM
35
3
Financhill
Back

Neurogene Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
12

NGNE
Neurogene

Last Price:
$22.57
Seasonality Move:
18.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 31.1% based on the past 10 years of stock performance.
  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $22.64. The Score for NGNE is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 31.1% based on the past 10 years of stock performance.

Neurogene Stock Rating

Sell
12
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
74.49
52-Week Low:
14.41

Prediction Charts

Market Cap:
336.3M
Price in USD:
22.64
Volume:
466.3K
Beta:
-1.35

Technical Analysis

SMA50:
37.38
SMA100:
38.10
SMA200:
37.89
52-Wk Change:
58.88%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 22.64 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 24.21 22.34 24.39 22.03
Dec-4 22.25 22.02 22.25 20.82
Dec-5 22.04 21.99 22.59 21.44
Dec-6 22.38 23.72 24.17 21.49
Dec-9 23.94 23.31 25.53 23.00
Dec-10 23.26 23.70 25.11 22.99
Dec-11 24.17 23.20 24.20 22.59
Dec-12 22.92 22.34 24.06 21.68
Dec-13 22.44 23.51 24.37 21.85
Dec-16 23.36 25.13 25.18 22.97
Dec-17 24.74 23.72 25.35 22.92
Dec-18 23.97 21.79 24.02 21.75
Dec-19 22.02 22.08 23.20 21.34
Dec-20 21.78 22.64 23.89 21.51

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.